Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNP
Volume: 60 - Issue: 6
First page: 474 - Last page: 478
C. Bachert - P.W. Hellings - V.J. Lund - W.J. Fokkens - C. Hopkins - B. Mayer - R.H. Chan - S.G. Smith - A.R. Sousa - R. Alfonso-Cristancho - S. Yang - on behalf of the SYNAPSE Study Group
DOI: 10.4193/Rhin22.053
Rhinology 60-6: 474-478, 2022
